In the vast, ever-evolving world of HIV research, study results can yield any number of ends. Some break entirely new ground; others answer important (or not-so-important) questions; still others follow up on earlier research to either support or refute those prior findings.
Regardless of their purpose, one of the common threads we seek in the studies we select for this series is that they further our conversation about important issues in HIV. This week, the research we've chosen adds these new sentences to a few ongoing conversations in the field:
- We probably don't need to be concerned about a direct impact of long-acting contraceptives on a woman's susceptibility to HIV.
- We sorely need to pay substantial attention to implementing cardiovascular health interventions for people with HIV.
- We're falling well short in our efforts to ensure HIV testing among people living in some of the hardest-hit areas of the U.S.
- We can probably consider E/C/F/TAF as a viable option for HIV post-exposure prophylaxis (PEP).